據報政府會對國泰(00293.HK)增資300億 包括貸款和入股
《南華早報》引述消息指,國泰(00293.HK)即將進行一項涉及400億元之資本重組計劃,其中政府會領頭,對公司增資近300億元。
據悉,政府將提供貸款融資,以及購入部份股權,同時會在董事局放置兩位「觀察員」。
據《彭博通訊社》引述知情人士透露,國泰正在權衡不同籌集資金方法,其中一個選擇是供股集資數十億美元,預期交易可能會在今日宣布。
目前太古(00019.HK)持有國泰45%股權,其次為國航(00753.HK)持有29.99%。
太古A(00019.HK)、太古B(00087.HK)、國航(00753.HK)、國泰今早起停牌,待刊發有關公司內幕消息的公告。(ic/ta/a)~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.